APA (7th ed.) Citation

Nettekoven, M., Adam, J., Bendels, S., Bissantz, C., Fingerle, J., Grether, U., . . . Ullmer, C. (2016). Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases. ChemMedChem, 11(2), 179-189. https://doi.org/10.1002/cmdc.201500218

Chicago Style (17th ed.) Citation

Nettekoven, Matthias, et al. "Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases." ChemMedChem 11, no. 2 (2016): 179-189. https://doi.org/10.1002/cmdc.201500218.

MLA (9th ed.) Citation

Nettekoven, Matthias, et al. "Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases." ChemMedChem, vol. 11, no. 2, 2016, pp. 179-189, https://doi.org/10.1002/cmdc.201500218.